09.12.25 -- Avoiding Alcohol-Induced Dose Dumping In Oral Drug Formulation

Explore the future of pharmaceutical packaging in this webinar from Adare Pharma Solutions. Discover how patient-centric designs, advanced safety systems, and sustainable materials are improving adherence and enabling innovative therapies. Learn how automation, digitalization, and regulatory guidance are reshaping packaging operations. Gain exclusive insights into trends, technologies, and partner selection strategies that will define the next decade—register today! Click here to learn more.

Chief Scientific Officer Jon Lenn discusses the balance of art and science in topical formulation development, emphasizing advanced skin models for optimized delivery, activity, and product stability.

Discover how PBPK models combined with in vitro tools and solubility enhancement expertise can be used to identify and mitigate absorption risks in early drug development.

Use this resource to decide whether tablets or liquid-filled, hard-shell capsules align seamlessly with the specific requirements of an active pharmaceutical ingredient and desired trial outcomes.

The FDA has become more vigilant about alcohol-induced dose dumping in extended-release oral dosages. Such dumping can result in anything from reduced therapeutic effects to dangerous toxicity. Let's take a closer look.

Without proper handling and packaging, the efficacy of probiotics can be compromised at any point in the packaging, storage, and transportation process, impacting shelf life and effectiveness.

Learn about the identification of CMAs, CPPs, and CQAs of drug products and how to predict their impact on formulation and manufacturing processes.

Personalized medicine can often provide more accurate dosing that ensures efficacy and helps achieve optimal therapeutic outcomes. A new generation of dosing technologies are emerging.

Gain insight into the benefits of outsourcing stability storage compared to handling in-house. By outsourcing stability storage, eliminate the need for maintaining in-house stability chambers or cabinets.

Explore 20+ new CDMO presenters in quick 20-minute sessions during Outsourced Pharma’s October Partner Week. Sessions include Analytical Services, ADC, Large and Small Molecules, Cell and Gene Therapy, and Fill/Finish. Each session offers a quick, informative look at capabilities to help you find the best-fit partner. Registration, on-demand access, and interactive Q&A are all free.

In this interview, Dr. Michael Grass discusses how the company is adapting to emerging trends in the CDMO landscape, driving innovation, and enhancing pharmaceutical product development.

Bring your pharmaceutical product to market with peace of mind, knowing your Intellectual Property (IP) is protected by our robust CARE system.

Why take the risk of selecting individual components that may not work well together? Find a containment system with proven container closure integrity, providing risk mitigation and convenience.

Integrity and transparent communication are fundamental to the interactions between a CDMO and its customers. They ensure efficient, effective, and phase-appropriate project management.